-
2023-503708-10-00
5
2024-02-20
Locally advanced or metastatic breast cancer
-
2022-500862-93-00
5
2024-02-01
Pulmonary Hypertension
-
2023-504807-94-00
7
2023-12-26
Breast Cancer; Advanced solid tumors including but not limited to gyne
-
2022-501316-34-00
4
2023-11-27
Patient cured from a primary cancer and at risk of 2nd cancer
-
2022-502974-18-00
10
2023-11-27
C. spp. prosthetic joint infection
-
2023-505266-29-00
7
2023-11-14
Advanced or metastatic solid tumors
-
2023-503582-35-00
6
2023-10-26
Staphylococcus aureus bacteremia
-
2023-503661-28-00
5
2023-10-26
Hidradenitis Suppurativa
-
2023-504618-31-00
5
2023-10-20
Chemotherapy induced peripheral neuropathy (CIPN)
-
2022-502755-59-00
1
2023-08-30
Locally Advanced or Metastatic Solid Tumors with FGFR3 Alterations
-
2022-500933-10-00
11
2023-08-02
Preeclampsia during pregnancy
-
2022-500967-11-00
5
2023-07-06
Previously Untreated Metastatic or Unresectable Melanoma
-
2024-514952-34-00
5
2023-06-23
Catheter related bloodstream infections due to Staphylococcus aureus
-
2024-513669-38-00
5
2023-05-17
Stroke, Ischemic, TIA, Cardiac Disease, Atherosclerosis, Myocardial In
-
2024-515146-16-00
5
2023-05-15
Colorectal surgery
-
2024-513195-18-00
5
2023-03-27
Severe asthma
-
2023-505259-39-00
7
2023-03-02
Acute Myeloid Leukemia (AML)
-
2022-500520-30-00
5
2023-03-01
neurology
-
2024-516172-15-00
4
2023-02-03
Chronic Obstructive Pulmonary Disease
-
2023-505634-94-00
10
2023-02-02
Subacute Cutaneous Lupus Erythematosus, Chronic Cutaneous Lupus Erythe
-
2022-501335-16-00
10
2023-01-16
Interstitial lung disease
-
2024-514913-37-00
11
2023-01-12
Respiratory distress
-
2024-514826-22-00
7
2022-12-05
Part A: Patients with advanced solid tumors or lymphomas.
-
2022-500234-29-00
5
2022-11-28
Rheumatoid Arthritis